Cargando…

Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants

INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubair, Muhammad Sulaiman, Maulana, Saipul, Widodo, Agustinus, Mukaddas, Alwiyah, Pitopang, Ramadanil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021037/
https://www.ncbi.nlm.nih.gov/pubmed/33828375
http://dx.doi.org/10.4103/jpbs.JPBS_261_19
_version_ 1783674672617881600
author Zubair, Muhammad Sulaiman
Maulana, Saipul
Widodo, Agustinus
Mukaddas, Alwiyah
Pitopang, Ramadanil
author_facet Zubair, Muhammad Sulaiman
Maulana, Saipul
Widodo, Agustinus
Mukaddas, Alwiyah
Pitopang, Ramadanil
author_sort Zubair, Muhammad Sulaiman
collection PubMed
description INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side affect and high inhibition potency are still in demand. OBJECTIVE: The objective of this study was to identify the potential compounds from Zingiberaceae plants that might be active as anti-HIV-1 by molecular docking. MATERIALS AND METHODS: Molecular docking simulation was performed by using AutoDock 4.2 on Linux operation system. Docking protocol was validated by using root mean square deviation (RMSD) value using redocking and cross-docking methods. The reported metabolites from Zingiberaceae plants were docked on HIV-1 protease, integrase, and reverse transcriptase protein enzymes. RESULTS: The docking result showed that the genera of Zingiber, Etlingera, Alpinia, Hedychium, and Boesenbergia have potential metabolites that inhibit HIV protease, integrase, and reverse transcriptase enzymes by possessing lower docking energy than native ligand of amprenavir, raltegravir, and nevirapine. Among the metabolites, noralpindenoside B and alpindenoside A from Alpinia densespicata inhibited protease enzymes with the lowest docking energy of -18.02 and -17.90 kcal/mol, respectively. Meanwhile, panduratin E from Boesenbergia pandurata Roxb. and 5α,8α-epidioxyergosta-6,22-dien-3β-ol from Etlingera elatior showed the lowest docking energy on integrase protein with docking energy of -11.97 and -11.41 kcal/mol, respectively. Pahangensin A from Alpinia pahangensis Ridley showed the lowest docking energy on reverse transcriptase enzyme with docking energy of -13.76 kcal/mol. CONCLUSION: The docking molecular study has identified the possible potential compounds from Zingiberaceae plants that might be used for anti-HIV-1 treatment. So, this study suggested further isolation and purification of the predicted compounds.
format Online
Article
Text
id pubmed-8021037
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80210372021-04-06 Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants Zubair, Muhammad Sulaiman Maulana, Saipul Widodo, Agustinus Mukaddas, Alwiyah Pitopang, Ramadanil J Pharm Bioallied Sci Original Article INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side affect and high inhibition potency are still in demand. OBJECTIVE: The objective of this study was to identify the potential compounds from Zingiberaceae plants that might be active as anti-HIV-1 by molecular docking. MATERIALS AND METHODS: Molecular docking simulation was performed by using AutoDock 4.2 on Linux operation system. Docking protocol was validated by using root mean square deviation (RMSD) value using redocking and cross-docking methods. The reported metabolites from Zingiberaceae plants were docked on HIV-1 protease, integrase, and reverse transcriptase protein enzymes. RESULTS: The docking result showed that the genera of Zingiber, Etlingera, Alpinia, Hedychium, and Boesenbergia have potential metabolites that inhibit HIV protease, integrase, and reverse transcriptase enzymes by possessing lower docking energy than native ligand of amprenavir, raltegravir, and nevirapine. Among the metabolites, noralpindenoside B and alpindenoside A from Alpinia densespicata inhibited protease enzymes with the lowest docking energy of -18.02 and -17.90 kcal/mol, respectively. Meanwhile, panduratin E from Boesenbergia pandurata Roxb. and 5α,8α-epidioxyergosta-6,22-dien-3β-ol from Etlingera elatior showed the lowest docking energy on integrase protein with docking energy of -11.97 and -11.41 kcal/mol, respectively. Pahangensin A from Alpinia pahangensis Ridley showed the lowest docking energy on reverse transcriptase enzyme with docking energy of -13.76 kcal/mol. CONCLUSION: The docking molecular study has identified the possible potential compounds from Zingiberaceae plants that might be used for anti-HIV-1 treatment. So, this study suggested further isolation and purification of the predicted compounds. Wolters Kluwer - Medknow 2020-11 2020-11-05 /pmc/articles/PMC8021037/ /pubmed/33828375 http://dx.doi.org/10.4103/jpbs.JPBS_261_19 Text en Copyright: © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Zubair, Muhammad Sulaiman
Maulana, Saipul
Widodo, Agustinus
Mukaddas, Alwiyah
Pitopang, Ramadanil
Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title_full Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title_fullStr Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title_full_unstemmed Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title_short Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
title_sort docking study on anti-hiv-1 activity of secondary metabolites from zingiberaceae plants
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021037/
https://www.ncbi.nlm.nih.gov/pubmed/33828375
http://dx.doi.org/10.4103/jpbs.JPBS_261_19
work_keys_str_mv AT zubairmuhammadsulaiman dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants
AT maulanasaipul dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants
AT widodoagustinus dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants
AT mukaddasalwiyah dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants
AT pitopangramadanil dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants